NVR VDL (Amlodipine besylate, hydrochlorothiazide and valsartan 10 mg / 12.5 mg / 160 mg)
Pill imprint NVR VDL has been identified as Amlodipine besylate, hydrochlorothiazide and valsartan 10 mg / 12.5 mg / 160 mg.
Amlodipine/hydrochlorothiazide/valsartan is used in the treatment of high blood pressure and belongs to the drug class miscellaneous antihypertensive combinations. There is positive evidence of human fetal risk during pregnancy. Amlodipine/hydrochlorothiazide/valsartan 10 mg / 12.5 mg / 160 mg is not a controlled substance under the Controlled Substance Act (CSA).
- Imprint:
- NVR VDL
- Strength:
- 10 mg / 12.5 mg / 160 mg
- Color:
- Yellow
- Shape:
- Elliptical / Oval
- Availability:
- Prescription only
- Drug Class:
- Miscellaneous antihypertensive combinations
- Pregnancy Category:
- D - Positive evidence of risk
- CSA Schedule:
- Not a controlled drug
- Manufacturer:
- Sandoz Inc
More about amlodipine/hydrochlorothiazide/valsartan
Consumer resources
- Amlodipine/valsartan/hydrochlorothiazide
- Amlodipine, hydrochlorothiazide, and valsartan
- Amlodipine, valsartan, and hydrochlorothiazide (Advanced Reading)
- Other brands: Exforge HCT
Professional resources
- Amlodipine, Valsartan, and Hydrochlorothiazide (FDA)
- Amlodipine, Valsartan, and Hydrochlorothiazide (Wolters Kluwer)
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
